Table 1 Clinical characteristics of the subjects.
From: A body shape index is associated with endothelial dysfunction in both men and women
Variables | Total (n = 8823) | Men (n = 6773) | Women (n = 2050) | P value |
|---|---|---|---|---|
Age (year) | 52 ± 13 | 51 ± 13 | 55 ± 15 | < 0.001 |
Body mass index (kg/m2) | 23.5 ± 3.4 | 23.8 ± 3.3 | 22.7 ± 3.8 | < 0.001 |
Height (m) | 1.66 ± 0.09 | 1.69 ± 0.06 | 1.55 ± 0.07 | < 0.001 |
Weight (kg) | 65.2 ± 11.9 | 68.3 ± 10.6 | 54.7 ± 9.6 | < 0.001 |
Waist circumference (cm) | 83.6 ± 9.5 | 84.7 ± 8.9 | 79.9 ± 10.7 | < 0.001 |
Systolic blood pressure (mmHg) | 128 ± 17 | 129 ± 16 | 124 ± 19 | < 0.001 |
Diastolic blood pressure (mmHg) | 79 ± 12 | 80 ± 12 | 75 ± 12 | < 0.001 |
Heart rate (bpm) | 65 ± 11 | 64 ± 11 | 67 ± 11 | < 0.001 |
Total cholesterol (mmol/L) | 5.17 ± 0.88 | 5.15 ± 0.88 | 5.22 ± 0.91 | 0.008 |
Triglycerides (mmol/L) | 1.46 ± 1.07 | 1.56 ± 1.15 | 1.15 ± 0.68 | < 0.001 |
HDL-C (mmol/L) | 1.53 ± 0.41 | 1.47 ± 0.39 | 1.71 ± 0.41 | < 0.001 |
LDL-C (mmol/L) | 3.03 ± 0.78 | 3.03 ± 0.78 | 3.03 ± 0.41 | 0.94 |
Glucose (mmol/L) | 5.66 ± 1.33 | 5.72 ± 1.33 | 5.55 ± 1.39 | < 0.001 |
Medical history, n (%) | ||||
Hypertension | 4177 (47) | 3132 (46) | 1045 (51) | < 0.001 |
Dyslipidemia | 4664 (53) | 3615 (53) | 1049 (51) | 0.08 |
Diabetes mellitus | 1107 (13) | 786 (12) | 321 (16) | < 0.001 |
Previous cardiovascular disease | 881 (10) | 712 (11) | 169 (8) | 0.002 |
Current smoker | 2482 (28) | 2321 (34) | 161 (8) | < 0.001 |
Medications, n (%) | ||||
Anti-hypertensive therapy | 2869 (33) | 2025 (30) | 844 (41) | < 0.001 |
Any lipid modification therapy | 1558 (18) | 1049 (15) | 509 (25) | < 0.001 |
Anti-hyperglycemic therapy | 781 (9) | 557 (8) | 224 (11) | < 0.001 |
Framingham risk score (%) | 8.6 ± 7.6 | 9.3 ± 8.0 | 6.1 ± 5.7 | < 0.001 |
FMD (%) | 5.7 ± 3.2 | 5.8 ± 3.1 | 5.7 ± 3.7 | 0.92 |
A body shape index | 0.0792 ± 0.0048 | 0.0788 ± 0.0041 | 0.0803 ± 0.0064 | < 0.001 |
